Pictet & Cie (Europe) Sa Bristol Myers Squibb CO Transaction History

Pictet & Cie (Europe) Sa

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$48.48 - $57.85 $29,087 - $34,710	-600 Reduced 5.06%	11,250 $577,000
Q3 2023 Nov 02, 2023	BUY	$57.89 - $64.73 $34,734 - $38,838	600 Added 5.33%	11,850 $687,000
Q2 2022 Aug 05, 2022	SELL	$72.62 - $79.98 $116,192 - $127,968	-1,600 Reduced 12.45%	11,250 $866,000
Q1 2022 May 04, 2022	SELL	$61.48 - $73.72 $398,083 - $477,337	-6,475 Reduced 33.51%	12,850 $938,000
Q4 2021 Feb 02, 2022	BUY	$53.63 - $62.52 $42,153 - $49,140	786 Added 4.24%	19,325 $1.21 Million
Q3 2021 Nov 10, 2021	SELL	$59.17 - $69.31 $21,478 - $25,159	-363 Reduced 1.92%	18,539 $1.1 Million
Q2 2021 Aug 11, 2021	SELL	$61.91 - $67.42 $74,539 - $81,173	-1,204 Reduced 5.99%	18,902 $1.26 Million
Q1 2021 May 10, 2021	SELL	$59.34 - $66.74 $23.3 Million - $26.2 Million	-392,066 Reduced 95.12%	20,106 $1.27 Million
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $702,811 - $796,413	12,172 Added 3.04%	412,172 $25.6 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $1.88 Million - $2.2 Million	34,340 Added 9.39%	400,000 $23.5 Million
Q1 2020 Apr 30, 2020	BUY	$46.4 - $67.43 $16.6 Million - $24.2 Million	358,230 Added 4821.4%	365,660 $20.4 Million
Q4 2019 Jan 31, 2020	BUY	$49.21 - $64.19 $365,630 - $476,931	7,430 New	7,430 $477,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.